Not applicableStudy completedNCT01009021What this trial is testingOral Diclofenac for Retinal Photocoagulation in Diabetic RetinopathyWho this might be right forPain University of Sao Paulo 30
Not applicableLooking for participantsNCT06899529What this trial is testingImmediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing VitrectomyWho this might be right forProliferative Diabetic Retinopathy - High Risk Christian Ophthalmic Surgery Expedition Network 150
Post-approval studies (Phase 4)Looking for participantsNCT06662994What this trial is testingHigh Dose Aflibercept in Diabetic Macular Edema in Patients With Previous VitrectomyWho this might be right forDiabetic Macular Edema (DME) Retina Consultants of Orange County 15
Testing effectiveness (Phase 2)Study completedNCT01281098What this trial is testingProspective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.Who this might be right forHigh Risk Proliferative Diabetic RetinopathyDiabetes Mellitus Type IDiabetes Mellitus Type II Association for Innovation and Biomedical Research on Light and Image 22
Not applicableStudy completedNCT03660384What this trial is testingSilicone Oil Versus Gas in PDR Patients Undergoing VitrectomyWho this might be right forDiabetic RetinopathyRetinal Detachment Rush Eye Associates 302
Post-approval studies (Phase 4)Not Yet RecruitingNCT07118670What this trial is testingHigh Dose Eylea for Proliferative Diabetic Retinopathy OutcomesWho this might be right forProliferative Diabetic Retinopathy (PDR) Edward Wood, MD 40
Not applicableStudy completedNCT06653361What this trial is testingUltra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic RetinopathyWho this might be right forProliferative Diabetic Retinopathy - High Risk Hayatabad Medical Complex 120
Testing effectiveness (Phase 2)Study completedNCT01102946What this trial is testingPanretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic RetinopathyWho this might be right forDiabetic RetinopathyRetinal Neovascularization University of Sao Paulo 40
Not applicableStudy completedNCT02995629What this trial is testingPatient Comfort Using Green vs. Yellow Pan Retinal PhotocoagulationWho this might be right forProliferative Diabetic Retinopathy - High Risk Wills Eye 40
Large-scale testing (Phase 3)Study completedNCT01941329What this trial is testingProspective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.Who this might be right forHigh Risk Proliferative Diabetic Retinopathy Association for Innovation and Biomedical Research on Light and Image 94
Testing effectiveness (Phase 2)UnknownNCT02630277What this trial is testingEvaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioNWho this might be right forProliferative Diabetic Retinopathy Valley Retina Institute 30
Testing effectiveness (Phase 2)Study completedNCT00511875What this trial is testingEvaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Thomas Gardner 30
Testing effectiveness (Phase 2)Study completedNCT01280929What this trial is testingProspective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic RetinopathyWho this might be right forHigh Risk Proliferative Diabetic Retinopathy José Cunha-Vaz 54